We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-2.1%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.12B
AUM Growth
-$506M
Cap. Flow
-$1.33B
Cap. Flow %
-25.88%
Top 10 Hldgs %
36.5%
Holding
171
New
28
Increased
20
Reduced
18
Closed
38

Top Buys

Rank Stock Value
1
NUVL
Nuvalent
NUVL
+$561M
2
WGS icon
GeneDx Holdings
WGS
+$144M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$39.4M
4
GKOS icon
Glaukos
GKOS
+$34.3M
5
AERI
Aerie Pharmaceuticals
AERI
+$31.4M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$54.4M
2
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$54.1M
3
QDEL icon
QuidelOrtho
QDEL
+$52.4M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$45.3M
5
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$42.5M

Sector Composition

Rank Sector Weight
1 Healthcare 66.12%
2 Financials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
126
Accendra Health
ACH
$247M
– –
-996,500
Closed -$42.2M
PBYI icon
127
Puma Biotechnology
PBYI
$407M
– –
-3,769,795
Closed -$34.6M
QDEL icon
128
QuidelOrtho
QDEL
$1.15B
– –
-409,219
Closed -$52.4M
RNAM
129
DELISTED
Avidity Biosciences
RNAM
– –
-560,132
Closed -$13.8M
STXS icon
130
Stereotaxis
STXS
$130M
– –
-1,843,000
Closed -$17.8M
XERS icon
131
Xeris Biopharma Holdings
XERS
$1.42B
– –
-6,553,398
Closed -$26.7M
ZBH icon
132
Zimmer Biomet
ZBH
$17.8B
– –
-348,140
Closed -$54.4M
NEUE
133
DELISTED
NeueHealth
NEUE
– –
-17,500
Closed -$24M
CMRX
134
DELISTED
Chimerix, Inc.
CMRX
– –
-1,816,221
Closed -$14.5M
ACHL
135
DELISTED
Achilles Therapeutics
ACHL
– –
-301,431
Closed -$2.95M
LUMO
136
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-33,117
Closed -$331K
RETA
137
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-300,000
Closed -$42.5M
MTACU
138
DELISTED
MedTech Acquisition Corporation Unit
MTACU
– –
-1,000,000
Closed -$10M
SNRHU
139
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
– –
-1,000,000
Closed -$10.1M
REVHU
140
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
– –
-1,000,000
Closed -$10.1M
OHPAU
141
DELISTED
Orion Acquisition Corp. Unit
OHPAU
– –
-500,000
Closed -$4.96M
IGNYU
142
DELISTED
Ignyte Acquisition Corp. Unit
IGNYU
– –
-725,000
Closed -$7.26M
CNVY
143
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
– –
-1,100,000
Closed -$12.5M
XENT
144
DELISTED
Intersect ENT, Inc
XENT
– –
-255,456
Closed -$4.37M
MAACU
145
DELISTED
Montes Archimedes Acquisition Corp. Unit
MAACU
– –
-2,000,000
Closed -$21.3M
CMIIU
146
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
– –
-600,000
Closed -$8.07M
CEREW
147
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
– –
-166,666
Closed -$2.4M
CHFW.U
148
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
– –
-500,000
Closed -$5.2M
CNST
149
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-1,601,427
Closed -$54.1M
2 3 4 5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2021 Portfolio in Review

As of Q3 2021, Deerfield Management held 171 positions worth $5.12B, down 9% from $5.63B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Deerfield Management withdrew a net $1.33B in Q3 2021, closing 38 positions and reducing 18 holdings. Its most notable exit was Zimmer Biomet, an estimated $54.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 68% a quarter earlier, followed by Financials.

Against the trend, Deerfield Management opened a new position in Nuvalent worth $436M.

  • Deerfield Management's largest Q3 2021 buy was Nuvalent: 19,341,024 shares worth $436M.
  • Deerfield Management added most to Neurocrine Biosciences in Q3 2021, an estimated $39.4M increase.
  • Deerfield Management's biggest Q3 2021 reduction was BioCryst Pharmaceuticals, cutting an estimated $41M.
  • Deerfield Management fully exited Zimmer Biomet in Q3 2021, selling an estimated $54.4M.
  • Deerfield Management's ten largest holdings make up 37% of its $5.12B portfolio in Q3 2021.
  • Deerfield Management opened 28 new positions and closed 38 in Q3 2021.
  • Deerfield Management's portfolio value fell 9% quarter-over-quarter to $5.12B.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.